
Boston Scientific
- Mapping and Ablation
- Venous Therapies
- Cardiac Rhythm Management
- Structural Heart
- Interventional Oncology
- Drug-Eluting Technologies
- Coronary
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Understanding Outcomes With the S-ICD in Primary Prevention Patients with Low Ejection Fraction (UNTOUCHED) Trial Primary Results
By
Boston Scientific
FEATURING
Michael Gold
By
Boston Scientific
FEATURING
Michael Gold
213 views
August 25, 2020
Dr. Michael R. Gold shares the primary endpoint results of the UNTOUCHED study as a ...
read more ↘ late breaking clinical trial at HRS 2020.
↖ read less
read more ↘ late breaking clinical trial at HRS 2020.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Cardiac Rhythm Management
Wed, Sep 22, 2021
Faculty: Boston Scientific , Adrian Hernandez , Camille Frazier-Mills , Marat Fudim
Faculty: Boston Scientific , Adrian Hernandez , Camille Frazier-Mills , Marat Fudim